Target intelligence / Profile preview

Nonstructural protein 5A (NS5A) (NS5A)

Target
NS5A
Molecular classification
Viral replication complex protein, Membrane-associated viral nonstructural protein, Zinc-metalloprotein
01

Overview

Nonstructural protein 5A (NS5A) is a membrane-associated, multifunctional zinc metalloprotein encoded by the hepatitis C virus (HCV) and is essential for viral RNA replication and virion assembly[1][2][3][7]. NS5A is organized into three domains, with domain I providing a structural scaffold and zinc binding, while domains II and III are involved in protein–protein interactions and regulation of replication, interferon resistance, and apoptosis[2][3][5][6]. NS5A interacts with viral components (e.g., NS5B polymerase, core protein) and host factors to form the HCV replication complex, acting as a molecular switch between replication and assembly[2][5][7]. It is the target of several direct-acting antiviral drugs, as inhibition of NS5A disrupts HCV life cycle stages critical for viral persistence in infected cells[7]. Resistance mutations in NS5A can confer antiviral treatment failure, making it important as both a therapeutic target and a molecular marker for monitoring therapy.

Other names
NS5AHepatitis C virus nonstructural protein 5A
02

Mechanism of action

Inhibition of NS5A blocks HCV replication and assembly; Blocks formation or function of the HCV replication complex; Interferes with RNA binding and protein–protein interactions critical for virus production

03

Biological functions

Viral RNA replicationVirion assembly and productionHost immune evasion (modulation of interferon response)Interaction with other viral and host proteinsRegulation of apoptosis
04

Disease associations

Infection (Hepatitis C virus infection, chronic hepatitis C)Indirectly linked to cancer (hepatocellular carcinoma as sequelae of chronic HCV)
05

Safety considerations

Development of resistance mutations during therapyNo known direct host toxicity; safety concerns are primarily related to resistance and not host effects
06

Interacting drugs

Daclatasvir

5 more in the full profile.

07

Biomarkers

NS5A resistance-associated variants (important for direct-acting antiviral therapy selection and efficacy monitoring)

Beyond the preview

Go deeper on Nonstructural protein 5A (NS5A) (NS5A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nonstructural protein 5A (NS5A) (NS5A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call